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Quantiﬁcationofneuromotorsymptomswithdevice-basedmeasuresprovidesausefulsupplementtoclinicalevaluation.Research
using the CATSYS has established its utility as a computerized measurement system to quantify neuromotor function. The
primary objective of this study is to provide technical guidance on the use of the CATSYS in Parkinson’s disease (PD). Forty-
four patients with idiopathic PD and 28 healthy controls were prospectively recruited and evaluated with CATSYS, a portable,
Windows-based system consisting of a data logger and four diﬀerent sensors (tremor pen, touch recording plate, reaction time
handle, and force plate for balance recording) for quantiﬁcation of neuromotor functions. CATSYS discriminated between PD and
controls on measurements of rest/postural tremor, pronation/supination, ﬁnger tapping, simple reaction time, and postural sway
intensity and velocity. CATSYS measurements using the proposed test battery were associated with relevant clinician-rated Uniﬁed
Parkinson’s disease rating scale (UPDRS) items assessing tremor and bradykinesia. More work is warranted to establish CATSYS
as a diagnostic/monitoring instrument in movement disorders using the proposed technical approaches.
1.Background
Quantiﬁcation of neuromotor symptoms such as tremor,
bradykinesia, and imbalance using objective, device-based
measures provides a useful supplement to clinical evalua-
tion. Research using the Coordination Ability Test System
(CATSYS, Danish Product Development Ltd., Denmark) has
established its utility as a sensitive computerized measure-
ment system to quantify normal and abnormal (clinical and
subclinical) neuromotor function. Normative data has been
obtained on 150 healthy men and women across ﬁve age
groups, all of whom were shown to be free of neurologic
deﬁcits at the time of testing [1]. CATSYS has been used
to assess the subtle neurological impact of exposure to toxic
agents [2, 3]. It has also been shown to detect diﬀerences in
dominant and nondominant hand tremor intensity among
tobacco users and nonusers in a cohort of male industrial
workers [4]. More recently, CATSYS has been used in
studies of neurologic and neurodegenerative disorders with
increasing frequency. Preliminary studies in patients with
Parkinson’sdisease(PD)haveshowntheabilityofCATSYSto
discriminate pathologic from physiologic (normal) tremor
in PD patients versus healthy controls [5]. Using bilateral
measurements taken with CATSYS, Farkas et al. [6]w e r e
able to distinguish between the two most common tremor
types, parkinsonian and essential tremor (ET), even at low
tremor intensities. Our group has published the results of a
pilotstudyofpre-andintraoperativeobjectivequantiﬁcation
of parkinsonian symptoms during high-frequency deep
brain stimulation (DBS) using permanently implanted brain2 Parkinson’s Disease
electrodes in the subthalamic nucleus for the treatment of
PD [7]. With the present work, we aim to provide our
readers with technical guidance for measuring parkinsonian
symptoms with CATSYS. We also present comparisons and
reference measurements for PD patients and controls.
2. Methods
2.1. Sample. We evaluated 44 patients with idiopathic
Parkinson’s disease (PD) recruited from the Movement
Disorders Clinic at the University of Miami Miller School
of Medicine. A diagnosis of PD was made according to the
UK PD Society Brain Bank criteria [8]. We also recruited
a group of 28 consecutive healthy volunteers for a compar-
ison group. Control participants were not matched to PD
participants, due to the consecutive nature of recruitment
in the departmental clinic. However, speciﬁc eﬀorts were
made to recruit healthy controls over 50 years old. All
participants were administered the CATSYS neuromotor
battery (participants with PD and motor ﬂuctuation were
evaluated in the “ON” state) and underwent comprehensive
neurologicevaluation.ClinicalassessmentofPDparticipants
also included the Uniﬁed Parkinson’s Disease Rating Scale
(UPDRS) III [9] (motor examination) during the “ON”
state. PD patients were on stable antiparkinsonian treatment
and received regular care from neurologists specializing in
movement disorders. The local institutional review board
approved the study, and all the participants gave written
informed consent. Demographic and clinical characteristics
are presented in Table 1.
2.2. Device. The Coordination Ability Test System (CAT-
SYS 2000; Danish Product Development, Ltd., Snekkersten,
Denmark, http://www.catsys.dk) is a portable, Microsoft
Windows-based system that consists of a data logger and
four diﬀerent sensors: a tremor pen, a touch recording
plate, a reaction time handle, and a force plate for balance
(static posturography) recording. The system quantiﬁes
numerous neuromotor functions including tremor (rest and
postural/action), reaction time, bradykinesia, and postural
sway.AllcollecteddataiseasilytransferredtoaPC,displayed
visually for the examiner, and readily exported for statistical
analysis. The system is highly portable and ﬁts in a briefcase
withatotalweightoflessthan10kg(seeFigure 1).Theentire
CATSYS evaluation can be carried out in 30minutes.
2.3. Tremor Pen. The Tremor Pen stylus (12cm×0.8cm)
contains a biaxial microaccelerometer and is sensitive in
a plane perpendicular to the pen axis. Through the pen’s
connection to the datalogger, vibrations in the patient’s
extremities are recorded and displayed in real-time. Fast
Fourier transformation analysis determines the normalized
power distribution of the tremor in the frequency band
0.9 to 15.0Hz. Quantiﬁcations generated from acceleration
data are based on the Fourier power. Four key variables are
calculated using the CATSYS software: (a) Tremor intensity,
(b) Center frequency, (c) Frequency dispersion, and (d)
Harmonic index. Tremor Intensity (TI) is the root mean
Table 1: Clinical Demographic Data for Sample.
PD Control
(n = 44)( n = 28)
M( S D ) M( S D )
Age 62.7 (9.5) 51.1 (16.9)
Gender: % M/F 71/29 54/46
Ethnicity: % Nonhispanic/Hispanic 51/49 57/43
Age of Onset 52.8 (11.3)
Disease Duration 9.0 (5.4)
Hoehn & Yahr Stage 2.3 (0.7)
UPDRS-III Motor Score 21.7 (9.8)
Figure 1: The Coordination Ability Test System (CATSYS) includ-
ing a data logger and four diﬀerent sensors: a tremor pen, a touch
recording plate, a reaction time handle, and a force plate for balance
(static posturography) recording.
squareofaccelerationrecordedinthe0.9to15Hzband.TIis
measuredinm/s2;largervaluesareindicativeofmoreintense
tremor. Center frequency (F50) is the median frequency
of the acceleration in the 0.9 to 15Hz band. A typical
PD resting tremor is between 4 and 6Hz [10]. Frequency
dispersion (SF50), or the standard deviation (SD) of center
frequency, represents the degree of irregularity of the tremor.
A regular tremor has little frequency dispersion, indicating
that most of the oscillations are within a narrow frequency
band. Harmonic index (HI) compares the tremor frequency
pattern with that of a single harmonic oscillation; a single
harmonic oscillation has an HI of 1.0. HI decreases when the
tremor is composed of frequent, irregular oscillations. For
typical, homogenous parkinsonian resting tremor, the HI is
close to 1.0. The tremor pen can be used to measure both
resting and postural/action tremor.
2.4. Touch Recording Plate. The circular Touch Recording
Plate (10cm in diameter) is a round drum which connects
to the datalogger and records each contact with the plate via
a sensitive microphone. Using the CATSYS software, the (a)
Mean frequency (Hz) of touches (MFT) and the (b) SD of
the mean frequency (MFT-SD) are calculated for each task.
The MFT is calculated as the total number of hits divided by
the recording time and is measured in Hz. The MFT-SD is
the deviation of hits from the average frequency calculated
metronome hits. A person who is able to maintain theParkinson’s Disease 3
same hit speed will have a small deviation from the average
frequency as opposed to a person with a variation in the hit
speed. The Touch Recording Plate can be used to measure
bradykinesia with a pronation/supination and ﬁnger tapping
task, as will be described below.
2.5. Reaction Time Handle. The Reaction Time Handle
(17cm long and 2.4cm in diameter) connects to the
datalogger which records the press/release of a black button.
A mechanical click response is also provided as feedback for
a successful response to the subject with each click. Audible
signalsareemittedfromthespeakeronthedataloggeratran-
dom intervals during a ﬁxed time period. Responses, which
are simple clicks with the thumb, are recorded in respect
to the time lapse between an audible signal and handle
click. Reaction times less than 0.10seconds are considered
invalid and are discounted by the software. Reaction times
larger than a user-speciﬁed “maximum reaction time” are
also excluded. The maximum permitted reaction time is a
predeﬁned waiting period. After each stimulus, the system
waits this amount of time for the reaction time handle to be
clicked.Ifnoclickoccurs,thenextperiodatwhichastimulus
is randomly emitted begins. Using the CATSYS software, the
(a) Mean reaction time (RT; measured in seconds) and the
(b) SD of the reaction time (RT-SD) are calculated for the
task. This device can be used to measure simple reaction
t i m e ,a sw i l lb ed e s c r i b e db e l o w .
2.6. Force Plate. The force plate is a rectangular static pos-
turography plate (40cm in length and 29cm in width) that
connects to the datalogger and records changes in vertical
force. The plate records weight measured in kilograms.
Forces along the vertical plane are recorded in three points
to determine the position of the center of force on the
plate. The movement of the force center in the XY-plane
deﬁned by the surface of the force plate is recorded in
time and analyzed to provide key variables. Transversal Sway
(TS) and Sagittal Sway (SS) are measured in mm and are
deﬁned as the mean of the x-a n dy-axis values of the force
center in a coordinate system with the mean force center
position as x = 0, y = 0. The Mean Sway (MS), deﬁned
as the simple mean of the distance from the geometrical
mean for center position to all recorded force positions, is
also measured in mm. The Sway Area (SA), deﬁned as the
area of the smallest polygon created by changes in force
along the x-a n dy-axes, includes the total trajectory of
the force center in the horizontal force plate plane. The
SA is calculated by looking at the force center trajectory
through a grid. This unit is measured in mm2.S w a yV e l o c i t y
(SV), the average travel speed of the force center in the
horizontal force plate plane, is calculated by dividing the
total length of the force center trajectory (mm) by the
recording period length (s). This unit is measured in mm/s.
Sway Intensity (SI) is calculated by taking the root mean
squareofaccelerationrecordedinthe0.1Hzto10.1Hzband.
SI is measured in mm/s2. The force plate can be utilized
to measure postural stability, as will be deﬁned in detail
below.
3. CATSYS Evaluation Protocol
3.1. Resting Tremor. With the hand in a relaxed position, the
tremorpenwasinsertedbetweentheindexandmiddleﬁnger
bordered by the thumb on the opposite side. Participants
were instructed to count backwards as a distracter task.
Resting tremor was measured for 8.2 seconds in each hand,
successively.
3.2. Postural Tremor. The tremor pen was inserted between
the index and middle ﬁnger while lying on the thumb.
Participants were asked to hold the pen horizontally, at eye
level, approximately 10cm from the nose with their elbow
joint at a right angle and free from the body. Participants
were instructed to count backwards as a distracter task.
Postural tremor was measured for 8.2seconds in each hand,
successively.
3.3. Pronation/Supination. The touch recording plate was
placed on a ﬂat surface next to the patient. Participants
were asked to tap, with their hand in an alternating prona-
tion/supination pattern, on the plate, as fast as possible with
the recording plate on a table in front of them. Performance
on the maximum frequency pronation/supination task was
measured for 10seconds for both the dominant and non-
dominant hand.
3.4. Finger Tapping. The touch recording plate was placed
on a ﬂat surface next to the patient. While seated with the
recording plate on a table in front of them, participants
were asked to position their thumb and middle ﬁnger to
straddle the touch recording plate with the wrist resting on
the table. Participants were asked to tap on the plate with
their index ﬁnger as quickly as possible, while raising the
index ﬁnger as far oﬀ the plate as possible between each
tap. Performance on the maximum frequency ﬁnger tapping
task was measured for 10seconds for the dominant and non-
dominant hand.
3.5. Simple Reaction Time. The reaction time handle was
placed in the patient’s hand, with the thumb situated
over the black “click” area. Participants were instructed to
respond to a series of randomly sequenced audible tones,
as fast as possible, by clicking the black area on the handle.
Performance on simple reaction time was measured in
response to nine randomly spaced tones during a 40-second
time period for both the dominant and non-dominant
hand.
3.6. Postural Stability. The Force Plate was placed on a ﬂat,
hard surface, and the participants were asked to stand on
the plate for a period of 80.5seconds with their eyes open.
Recording began after a 10-second run-in period. There was
also a ﬁve-second run-out period, so that the recording time
for PI was 65.5seconds. This task was only completed in the
outpatient setting.4 Parkinson’s Disease
Table 2: CATSYS Values for PD and Control Participants.
PD Control
NMS D N MSD
CATSYS Rest TI
∗ 44 1.34 3.02 28 0.10 0.07
CATSYS Rest F50 44 6.63 2.33 28 6.84 3.08
CATSYS Rest SF50 44 2.22 1.34 28 2.61 1.16
CATSYS Rest HI
∗∗ 44 0.92 0.06 28 0.88 0.07
CATSYS Postural TI
∗ 44 1.75 3.20 18 0.21 0.30
CATSYS Postural F50 44 6.20 1.98 18 4.96 2.40
CATSYS Postural SF50 44 2.33 1.56 18 2.93 1.48
CATSYS Postural HI 44 0.91 0.06 18 0.89 0.06
CATSYS Pronation/Supination (events/s)∗ 40 2.45 0.81 18 3.43 0.60
CATSYS SD of Pronation/Supination (events/s)∗ 40 1.29 0.34 18 1.65 0.23
CATSYS Finger Tapping (events/s)∗∗ 38 3.83 1.01 18 4.63 0.82
CATSYS SD Finger Tapping (events/s) 38 1.57 0.26 18 1.68 0.17
CATSYS Reaction Time (s)
∗∗ 42 0.41 0.21 22 0.29 0.06
CATSYS SD of Reaction Time (s)
∗∗ 42 0.11 0.08 22 0.07 0.05
CATSYS Mean Sway (mm) 7 7.83 5.24 10 4.90 1.16
CATSYS Transversal Sway (mm) 7 3.29 2.55 10 2.84 1.15
CATSYS Sagittal Sway (mm)∗∗ 7 6.53 4.09 10 3.40 0.87
CATSYS Sway Area (mm2) 7 1375.57 2816.46 10 188.60 91.62
CATSYS Sway Intensity∗∗ 7 9.15 8.57 10 3.40 0.70
CATSYS Sway Velocity (mm/s)∗∗ 7 12.89 7.43 10 7.24 1.67
∗p<. 001
∗∗ p<. 05
4.StatisticalAnalysis
Spearman correlation coeﬃcients were used to examine the
relationship between UPDRS-III motor scores and CATSYS
measurements. Mann-Whitney U tests were used for group
comparisons between PD and healthy control groups, as
CATSYS measurements for the PD group violated normality
assumptions. The most aﬀected side (i.e., the side with the
worst task performance) of the PD participants (identiﬁed
for each task) was compared with the performance of the
worst performing side of the healthy control group for all
upper extremity measures. A probability value (p)o f≤.05
was considered signiﬁcant for all analyses. Statistical analyses
were performed using SPSS for Windows 17.0 (SPSS Inc.,
Chicago, IL).
5. Results
5.1. Relationship of CATSYS and UPDRS. CATSYS values
were collected for upper extremity tremor (resting and
postural), bradykinesia (pronation/supination and ﬁnger
tapping), and reaction time. Postural sway data was collected
for a subset of PD participants (n = 7) and healthy controls
(n = 10).
5.2. Resting Tremor. Both right and left CATSYS resting TI
scores were signiﬁcantly correlated with the right and left
values for UPDRS item 20 (Right ρ = .680, p<. 001; Left
ρ = .739, p<. 001).
5.3. Postural Tremor. Both right and left CATSYS postural
TI scores were signiﬁcantly correlated with the right and left
values for UPDRS item 21 (Right ρ = .803, p<. 001; Left
ρ = .793, p<. 001).
5.4. Bradykinesia. The mean value for CATSYS prona-
tion/supination ([R + L]/2) was calculated and was signiﬁ-
cantlycorrelatedwithUPDRSitem31(ρ =− .411, p<. 014).
CATSYS ﬁnger tapping values for the left and right hand
show no relationship with UPDRS bradykinesia items (all
ps > .05).
5.5. CATSYS Discriminates between PD and Control Subjects.
The PD group demonstrated greater resting TI (U = 278.0,
p<. 001)andahigherHI(U = 379.5, p<. 007)thanhealthy
controls. Postural TI (U = 164.5, p<. 001) was also greater
in PD. The PD group exhibited slower pronation/supination
movements (U = 125.5, p<. 001) and a lower SD of
pronation/supination frequency (U = 129.5, p<. 001) than
healthy controls. Finger tapping (U = 178.0, p<. 005)
and reaction time (U = 275.0, p<. 009) were slower
in PD compared to controls. In the subset of participants
who underwent the static posturography assessment, the PD
group showed more sway in the sagittal plane (U = 13.5, p<
.037) and demonstrated greater overall sway intensity (U =
9.0, p<. 012) and velocity (U = 8.0, p<. 009) than healthy
controls. All other standard CATSYS measurements failed to
discriminate between PD and healthy controls. Means andParkinson’s Disease 5
standard deviations for all CATSYS values are presented in
Table 2.
6. Discussion
This study provides technical guidance on the use of the
CATSYS and proposes a battery of tests to help investigators
obtain uniform/standardized data. The CATSYS system
demonstrated clinically relevant measurement feasibility of
selected parkinsonian symptoms relative to the UPDRS.
These preliminary data suggest that the CATSYS system
is able to discriminate between PD patients and healthy
individuals without evidence of disordered movements. The
purpose of the current study was not to evaluate the
diagnostic utility of the CATSYS system, but to describe
how it can be used to provide objective measurements of
parkinsonian symptoms. CATSYS oﬀers an opportunity to
quantify objectively several parkinsonian motor symptoms
and supplement clinician observation. Unlike traditional
clinical rating scales that utilize categorical ratings, the
CATSYS quantiﬁes motor performance on a continuum,
allowing for greater precision in recording subtle change in
PD motor symptomatology.
6.1. CATSYS Versus Other Computerized Assessment Tools.
Other methods are available which permit the objective
assessmentofmotorsymptomatology.Thereareatleasteight
systems that have been published with data demonstrating
the ability to quantify PD motor symptoms [7, 11–17]. Each
system utilizes a diﬀerent methodology and a unique set
of strengths and weaknesses. Compared to other available
tools, CATSYS oﬀers the ability to assess a wider range of
symptoms and to date is the only system available that has
been used to measure lower extremity symptoms [18]. The
CATSYSalsooﬀerstheabilitytoquantifyposturalinstability,
a key feature of advanced PD not measured by the other
available systems. Other major advantages of the CATSYS
include the availability of normative data, portability, and
ease of administration.
7. Conclusions
Using a noninvasive, simple, and sensitive electronic record-
ing method of symptom registration, we were able to
objectively quantify parkinsonian neuromotor symptoms
and provide reference values that diﬀerentiate patients from
control subjects. More work is warranted to establish CAT-
SYS as a diagnostic or monitoring instrument in movement
disorders using the proposed technical approaches
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